Status:
COMPLETED
Comparative Effectiveness Feasibility Trial for Insomnia Among Breast Cancer Survivors
Lead Sponsor:
George Washington University
Conditions:
Breast Cancer Female
Insomnia
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
Women with breast cancer who report insomnia that started or worsened during breast cancer diagnosis and treatment will be enrolled in a group behavioral trial to one of two arms testing cognitive beh...
Detailed Description
The investigators are recruiting breast cancer survivors with stage I-III or Eastern Cooperative Oncology Group 0-1 breast cancer to enroll in a group-delivered behavioral trial for insomnia. The inve...
Eligibility Criteria
Inclusion
- American Joint Committee on Cancer (AJCC) Stage I-III or Eastern Cooperative Oncology Group (ECOG) 0-1 breast cancer
- completed active treatment (surgery, radiation, chemotherapy) at least three months prior
- within 5 years of treatment or still on adjuvant therapy
- Completes informed consent to participate
Exclusion
- sleep apnea or restless leg syndrome
- practicing mindfulness techniques \>1/wk
Key Trial Info
Start Date :
April 15 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 28 2018
Estimated Enrollment :
26 Patients enrolled
Trial Details
Trial ID
NCT03328169
Start Date
April 15 2017
End Date
June 28 2018
Last Update
August 15 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
GW Center for Integrative Medicine
Washington D.C., District of Columbia, United States, 20052